# Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/sacituzumab-govitecan-hziy-in-refractory-metastatic-triple-negative-breast/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Aditya Bardia,Ingrid A. Mayer,Linda T. Vahdat,Sara M. Tolaney,Steven J. Isakoff,Jennifer R. Diamond,Joyce O’Shaughnessy,Rebecca Moroose,Alessandro D. Santin,Vandana G. Abramson,Nikita Shah,Hope S. Rugo,David M. Goldenberg,Ala M. Sweidan,Robert Iannone,Sarah A. Washkowitz,Robert M. Sharkey,William A. Wegener,Kevin Kalinsky |
| Citations | 858 |
| DOI | 10.1056/nejmoa1814213 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2917403028 |
| PMID | 30786188 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Joyce O’Shaughnessy](https://scholariq.org/researchers/joyce-o-shaughnessy/)

## Paper journal

- [New England Journal of Medicine](https://scholariq.org/journals/new-england-journal-of-medicine/)

## Paper primary topic

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

## Paper topics

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [Peptidase Inhibition and Analysis](https://scholariq.org/topics/peptidase-inhibition-and-analysis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.